Sei Investments CO Abcam PLC Transaction History

Sei Investments CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$21.54 - $24.41 $862,181 - $977,059	-40,027 Reduced 25.85%	114,815 $2.6 Million
Q2 2023 Aug 11, 2023	SELL	$12.62 - $24.47 $192,997 - $374,219	-15,293 Reduced 8.99%	154,842 $3.79 Million
Q1 2023 May 12, 2023	BUY	$12.98 - $17.1 $513,371 - $676,322	39,551 Added 30.29%	170,135 $2.29 Million
Q4 2022 Feb 10, 2023	BUY	$13.92 - $17.0 $311,070 - $379,899	22,347 Added 20.65%	130,584 $2.03 Million
Q3 2022 Nov 14, 2022	BUY	$13.36 - $16.75 $57,448 - $72,025	4,300 Added 4.14%	108,237 $1.62 Million
Q2 2022 Aug 15, 2022	BUY	$12.69 - $19.25 $247,581 - $375,567	19,510 Added 23.11%	103,937 $1.5 Million
Q1 2022 May 13, 2022	BUY	$15.5 - $23.89 $44,392 - $68,420	2,864 Added 3.51%	84,427 $1.54 Million
Q4 2021 Feb 14, 2022	SELL	$20.04 - $23.84 $10,020 - $11,920	-500 Reduced 0.61%	81,563 $1.92 Million
Q3 2021 Nov 12, 2021	SELL	$17.38 - $21.54 $67,677 - $83,876	-3,894 Reduced 4.53%	82,063 $1.66 Million
Q2 2021 Aug 06, 2021	BUY	$18.47 - $22.11 $1.59 Million - $1.9 Million	85,957 New	85,957 $1.64 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.